Optimal TKI use for oncogene-addicted non-small cell lung cancer
Phase 2 trial of chemotherapy plus gefitinib as first-line treatment for lung adenocarcinoma
Exciting results from the ALEX trial
What is the best treatment for RAS wild-type metastatic colorectal cancer?
Eagerly anticipated results of the FLAURA trial